Physician
Anesthesiology
Dr. Mohammad S. Iqbal, MD
|
|
Give Review
Mohammad Iqbal works in the field of Anesthesiology. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Mohammad S. Iqbal is a published physician as well. He has 40 publications published. The latest was: Gold levels produced by treatment with auranofin and sodium aurothiomalate. He accepts all Medicare patients.
Publications
- Fabrication of potential macromolecular prodrugs of aspirin and diclofenac with dextran.
- Antibacterial dimeric copper(II) complexes with chromone-derived compounds.
- Comparative study of pharmaceutical properties of some new derivatives of sulfamethoxazole.
- Mechanochemical synthesis and in vitro anti-Helicobacter pylori and uresase inhibitory activities of novel zinc(II)-famotidine complex.
- 4-(2-Ethyl-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.
- 4-(3-Nitro-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.
- 4-(3-Methoxy-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.
- 4-(2-Fluoro-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.
- 1-(2-Oxoindolin-3-yl-idene)-4-[2-(trifluoro-meth-oxy)phen-yl]thio-semi-carbazide.
- 1-[2-Oxo-5-(trifluoro-meth-oxy)indolin-3-yl-idene]-4-[4-(trifluoro-methyl)-phen-yl]thio-semicarbazide.
- 4-(5-Chloro-2-methyl-phen-yl)-1-[2-oxo-5-(trifluoro-meth-oxy)indolin-3-yl-idene]thio-semicarbazide.
- Methyl 2-methyl-3,5-dinitro-benzoate.
- In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance.
- A simple method for simultaneous determination of some organic liquids in in-process materials and effluents produced in the manufacture of amoxicillin and ampicillin.
- N''-[(1E)-1-(4-Chloro-phen-yl)ethyl-idene]formohydrazide.
- N''-[(E)-(4-Bromo-2-thien-yl)methyl-idene]benzohydrazide 0.06-hydrate.
- N''-[(E)-(4-Bromo-2-thienyl)methyl-ene]isonicotinohydrazide.
- N''-[(E)-4-Hydr-oxy-3-methoxy-benzyl-idene]pyridine-4-carbohydrazide.
- N''-[(E)-4-Hydr-oxy-3-methoxy-benzyl-idene]benzohydrazide.
- N''-[(E)-1-(3-Fluoro-phen-yl)ethyl-idene]formohydrazide.
- (Z)-4-Hexyl-1-(5-nitro-2-oxo-2,3-dihydro-1H-indol-3-yl-idene)thio-semicarbazide.
- 1-(5-Nitro-2-oxoindolin-3-yl-idene)-4-o-tolyl-thio-semicarbazide methanol monosolvate.
- N''-[(E)-(5-Methyl-furan-2-yl)methyl-idene]formohydrazide.
- (2-Amino-phen-yl)[(5S)-5-hydr-oxy-3,5-dimethyl-4,5-dihydro-1H-pyrazol-1-yl]methanone.
- 3-Amino-2-methyl-4-oxo-3,4-dihydro-quinazolin-1-ium p-toluene-sulfonate monohydrate.
- 2-[6-Thioxo-5-(2,4,6-trimethyl-phen-yl)-1,3,5-thia-diazinan-3-yl]acetic acid.
- 3-Benzyl-5-butyl-1,3,5-thia-diazinane-2-thione.
- (2R)-2-(1,3-Dioxoisoindolin-2-yl)-4-(methyl-sulfan-yl)butanoic acid.
- 2-Hydr-oxy-3-nitro-benzamide.
- 2-Hydr-oxy-5-nitro-benzamide.
- 3-Hydr-oxy-N''-[(Z)-(5-methyl-2-fur-yl)methyl-idene]naphthalene-2-carbo-hydrazide.
- Mutual prodrug of cephazolin and benzydamin: 3-[(1-benzyl-1H-indazol-3-yl)-oxy]-N,N-dimethyl-propan-1-aminium 3-{[(5-methyl-1,3,4-thia-diazol-2-yl)sulfan-yl]meth-yl}-8...
- In vitro cytotoxic, antibacterial, antifungal and urease inhibitory activities of some N4- substituted isatin-3-thiosemicarbazones.
- Pharmacokinetic study of copper (II) acetylsalicylate.
- Degradation of atorvastatin: (1R,2S,4S,5S)-4-(4-fluoro-phen-yl)-2-hydro-peroxy-4-hydr-oxy-2-isopropyl-N,5-diphenyl-3,6-dioxabicyclo-[3.1.0]hexane-1-carboxamide.
- 3-(2-Benzamido-phen-yl)-4-(4-hydroxy-phen-yl)-5-methyl-4H-1,2,4-triazol-1-ium chloride.
- Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
- Synthesis of some N4-substituted isatin-3-thiosemicarbazones.
- Gold levels produced by treatment with auranofin and sodium aurothiomalate.
Doctors Specialties
- Anesthesiology
- Pain Medicine Anesthesiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Drug Facts
| NPI NUMBER | 1235137340 | |
| NPPES Provider LastName | IQBAL | |
| NPPES Provider FirstName | MOHAMMAD | |
| NPPES Provider ZIPCode | 503143034 | |
| NPPES Provider State | IA | |
| Specialty Description | Interventional Pain Management | |
| Total Claim Count | 2239.0 | |
| Distinct Opioid Count | 14.0 | |
| Opioid Claim Count | 1346.0 | |
| Percent Opioid Claims | 60.12 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235137340 |
| Last Name Of The Provider | IQBAL |
| First Name Of The Provider | MOHAMMAD |
| View All |
Similar Doctors
|
Dr. John U. Skoog, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Myrdalis A. Diaz-Ramirez, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark D. Woiwood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zane Hurkin, DO |
|
|
Dr. Darin L. Frerichs, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas Monachino, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Blythe E. Harris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Josef A. Granwehr, MD |
|
|
Dr. George Lederhaas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Jabour, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brent R. Thurness, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Louis J. Dewild, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenton J. Hall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas J. Aerisolphal, MD |
|
Dr. Daniel M. Waller, MD
This Doctor is OpenDoctor Recommended.
|